Stock listing
NASDAQ:SCLN SciClone Pharmaceuticals Inc Stock
Follow SciClone Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SCLN
$11.15 USD
Close on Oct 13, 2017 · No longer trades
- Lowest – highest close
- $0.68 – $20.63 USDSince Dec 31, 1997 · lowest Dec 30, 2008 · highest Mar 7, 2000
Delisted NASDAQ:SCLN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SCLN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
SciClone Pharmaceuticals Inc on 6ix
- Decks
- 3 decks · latest Jan 7, 2013
Where SciClone Pharmaceuticals Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SCLN · This page · Delisted | NASDAQ | United States | USD |
| HKEX:6600 臥安機器人 · Delisted | HKEX | Hong Kong | HKD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2013) | Investor deck | 22 slides | Jan 7, 2013 |
| Investor Presentation (January 2010) | Investor deck | 22 slides | Jan 11, 2010 |
| Proxy Contest (February 2009) | Proxy contest | 35 slides | Feb 9, 2009 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Peter Barrett Other companies: Obsidian Therapeutics, Inc. (Board Member · Since at least Aug 3, 2026); Synlogic Inc (Chairman, Partner, Atlas Venture · Since at least Aug 28, 2017); Revvity, Inc. (Partner, Atlas Venture · Since at least Feb 6, 2012); Vitae Pharmaceuticals Inc (Director · Sep 24, 2014 – Sep 29, 2014 · Past); Larimar Therapeutics, Inc. (Director · Jun 18, 2014 – May 10, 2022 · Past); Momenta Pharmaceuticals Inc (Director · Jun 15, 2006 – Jun 5, 2008 · Past); Alnylam Pharmaceuticals, Inc. (Director · Feb 23, 2006 – Jun 1, 2006 · Past) | Director · Apr 18, 2011 – Jun 7, 2012 · Past |
| Nancy Chang Other companies: Immix Biopharma, Inc. (Independent Director · Since at least Sep 8, 2025); Galera Therapeutics, Inc. (Director · Since at least Dec 30, 2024); W&T Offshore, Inc. (Director · Since at least Apr 28, 2023); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); Charles River Laboratories International, Inc. (Director · Oct 24, 2007 – May 7, 2010 · Past); Tanox Inc (Director · Dec 31, 2005 – Nov 2, 2006 · Past) | Director · Sep 17, 2013 – Oct 13, 2017 · Past |
| Anthony Gregg Lapointe Other companies: Astria Therapeutics Inc (Director · Since at least Jan 3, 2019); Rigel Pharmaceuticals, Inc. (Director · Since at least Oct 31, 2017); Soligenix, Inc. (Director · Since at least Mar 10, 2009); Raptor Pharmaceutical Corp (Director · Jan 1, 2015 – Oct 24, 2016 · Past); Questcor Pharmaceuticals Inc (Director · Oct 9, 2009 – Jan 1, 2010 · Past) | Director · Mar 30, 2009 – Oct 13, 2017 · Past |
| Jon S. Saxe Other companies: Vistagen Therapeutics, Inc. (Chair of the Board · Since at least May 11, 2011); Durect Corporation (Director · Jun 20, 2006 – Jun 17, 2020 · Past); Sciele Pharma Inc (Director · Jun 15, 2006 – May 23, 2008 · Past); PDL BioPharma Inc (Director · Jan 4, 2006 – Apr 9, 2008 · Past); Questcor Pharmaceuticals Inc (Director · Jan 1, 2006 – Jan 1, 2006 · Past) | Director · Jun 13, 2006 – Oct 13, 2017 · Past |
| Richard J. Hawkins Other companies: Plus Therapeutics, Inc. (Director · Since at least Jun 25, 2020); Savara, Inc. (Audit Committee · Since at least Dec 17, 2017); Lumos Pharma Inc (Chief Executive Officer, Director · Mar 18, 2020 – Dec 12, 2024 · Past) | Director · Oct 13, 2017 – Oct 13, 2017 · Past |
| Gary Titus Other companies: Kosan Biosciences Inc (Sr. VP and CFO · Sep 5, 2006 – Jun 26, 2008 · Past); Oruka Therapeutics, Inc. (Chief Acct.Officer · Aug 1, 2006 – Aug 30, 2006 · Past) | Senior VP Finance & CFO · Dec 8, 2008 – May 31, 2012 · Past |
| Stephanie Wong Other companies: AN2 Therapeutics, Inc. (Director · Since at least Mar 24, 2022); Calithera Biosciences, Inc. (See Remarks · Jan 1, 2017 – Jan 23, 2023 · Past) | VP, Finance and Controller · Aug 3, 2012 – Apr 4, 2013 · Past |
| Dean S Woodman Other companies: MarineMax, Inc. (fl) (Director · Dec 30, 2005 – Aug 7, 2019 · Past) | Director · Jun 13, 2006 – May 23, 2011 · Past |
| Raymond Anthony Low Other companies: AXT Inc (Chief Financial Officer · Feb 26, 2007 – Nov 5, 2012 · Past) | VP, Finance & Controller, Director · Oct 15, 2013 – Oct 13, 2017 · Past |
| Wilson Wai-Shun Cheung Other companies: AXT Inc (Chief Financial Officer · Oct 27, 2006 – Nov 10, 2008 · Past) | CFO & Senior VP, Finance · Jul 16, 2013 – Oct 13, 2017 · Past |
All 20 people
| Person | Seat |
|---|---|
| Carey Chern | General Counsel · Nov 14, 2016 – Oct 13, 2017 · Past |
| Friedhelm Blobel | President, CEO, Director, Director · Jun 2, 2006 – Oct 13, 2017 · Past |
| Hans P Schmid | Pres & Mng Dir, SciClone Int'l · Feb 23, 2006 – May 14, 2010 · Past |
| Israel Rios | Sr. VP, Medical Affairs & CMO · Mar 13, 2012 – Mar 15, 2012 · Past |
| John D Baxter | Director · Jun 13, 2006 – May 21, 2009 · Past |
| Lan Xie | VP Finance, China CFO · Aug 3, 2012 – Oct 13, 2017 · Past |
| Min Yin | VP Compliance & Internal Audit · Jun 7, 2012 – Mar 14, 2014 · Past |
| Roberto Camerini | Director · Mar 30, 2009 – Jun 14, 2011 · Past |
| Simon Li | Director · Jan 10, 2013 – Oct 13, 2017 · Past |
| Trevor M Jones | Director · Mar 30, 2009 – Jun 30, 2011 · Past |
Log in to ask 6ix AI your own questions about SciClone Pharmaceuticals Inc.